Cell Therapy Catapult - Articles and news items

Positive interim review in ongoing AML WT1 T cell clinical trial

Industry news / 14 April 2016 / Victoria White, Digital Content Producer

The Cell and Gene Therapy Catapult has announced a positive interim review of a Phase I/II trial using WT1-TCR t-cell therapy to target acute myeloid leukaemia…

Cell Therapy Catapult awards major contract to CTL

Industry news / 3 August 2015 / Victoria White

Cell Therapy Catapult has awarded a contract to CTL to accelerate its clinical programme to develop an engineered T cell treatment for blood cancers…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+